Skip to main content
. 2013 Nov 26;110(2):271–277. doi: 10.1038/bjc.2013.726

Figure 4.

Figure 4

Comparison of overall survival and progression-free survival among patient subgroups treated with a standard dose of weekly paclitaxel (wPTX; arm A) versus escalated-dose wPTX (arm B). Abbreviations: HR, hazard ratio; OS, overall survival; PFS, progression-free survival.